Search clinical trials for: Placebo, then Naltrexone

Total 64326 results

University of Wisconsin, Madison

Completed

Attenuation of Pain in Men and Women

Pain

United States
University of California, San Francisco

Completed

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Multiple Sclerosis

United States
University Hospital, Limoges

Completed

Assessment of an Automated Telesurveillance System on the Incidence of Serious Falls in Nursing Homes (TELEHPAD)

The Elderly of 75 Years and Living in Nursing Homes

France
San Diego State University

Recruiting

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

Placebo | Naltrexone

United States
Alkermes, Inc.

Completed

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

Alcoholism
University of Bern
University Hospital Inselspital, Berne

Completed

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

Neuroscience of Dreaming, Healthy

Switzerland
University of Pennsylvania
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Opioid-Related Disorders | Heroin Dependence

United States, Russian Federation
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Alcohol Pharmacotherapy for HIV+ Prisoners (INSPIRE)

Alcohol Dependence | Human Immunodeficiency Virus | AIDS | Hazardous Drinking | Problem Drinking

United States
University of Chicago
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Efficacy of Naltrexone in Women's Smoking Cessation

Smoking | Smoking Cessation

United States
H. Lundbeck A/S

Completed

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Alcohol Dependence

United Kingdom
Drug Delivery Company, LLC DBA Akyso Pharmaceuticals
National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive...

Not yet recruiting

A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults

Opioid Use Disorder
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Alcohol Drinking

United States
Allodynic Therapeutics, Inc

Completed

An Acute Migraine Factorial Study (ANODYNE-1)

Migraine With or Without Aura

United States
Allodynic Therapeutics, LLC

Completed

Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine (ANODYNE-1)

Migraine With or Without Aura

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana

Marijuana Use
Elite Laboratories, Inc

Completed

A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery

Pain

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone for Heavy Drinking in Young Adults

Alcoholism | Alcohol Consumption | Alcoholic Intoxication | Alcohol-induced Disorders

United States
Alkermes, Inc.

Completed

ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults

Alcohol Dependence

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Cocaine Use Reduction With Buprenorphine (CURB)

Cocaine Dependence

United States
Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
Lung Institute

Withdrawn

Crossover Blinded Trial of Cell Therapy Versus Placebo in COPD

COPD | Chronic Bronchitis | Emphysema or COPD

United States
Alkermes, Inc.

Terminated

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Alcoholism | Opiate Dependence
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer

Quality of Life | Breast Cancer

Taiwan
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Maintenance Treatment of Alcoholism

Alcoholism

United States
Alkermes, Inc.

Completed

ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence

Alcohol Dependence
Odense University Hospital
University of Southern Denmark; University Hospital Bispebjerg and Frederiksberg

Completed

Fibromyalgia and Naltrexone: The FINAL Study (FINAL)

Fibromyalgia

Denmark
US Department of Veterans Affairs

Completed

Treating Alcohol Use In Older Adults With Depression

Depression | Alcoholism

United States
Shenzhen Sciencare Medical Industries Co., Ltd.

Recruiting

Exploring the PK of Different Doses of Naltrexone in Patients With AUD

AUD

China
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
State University of New York - Upstate Medical...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Treatment of Alcohol Abuse in Schizophrenia

Mental Disorders | Alcoholism | Schizophrenia | Alcohol Abuse | Alcohol-related Disorders

United States
Yale University
National Center for Responsible Gaming

Completed

Investigation of Naltrexone for Pathological Gambling

Pathological Gambling

United States
VA Loma Linda Health Care System

Completed

Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude

Sleep Apnea, Central | Altitude

United States
Yale University
Ethel F. Donaghue Women's Health Investigator Program at Yale

Completed

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Obesity | Schizophrenia | Schizoaffective Disorder

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Treatment for Alcoholic Women

Alcoholism | Eating Disorder

United States
Texas Tech University
Texas Tech University Health Science Center

Recruiting

Naltrexone for Prolonged Grief Disorder (NPGD)

Placebo | Naltrexone HCl 50 MG Oral Tablet

United States
Finnish Institute for Health and Welfare

Completed

Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

Pathological Gambling

Finland
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Human Immunodeficiency Virus | Opiate Dependence

Russian Federation
Pennington Biomedical Research Center
Weight Watchers International

Completed

Energy Cost for Holding a MedGem® Indirect Calorimeter (MEDGEM)

Resting Metabolic Rate

United States
Luis Nacul
University of British Columbia; Canadian Institutes of Health Research (CIHR); Provincial Health Services Authority and other collaborators

Recruiting

Low-dose Naltrexone for Post-COVID Fatigue Syndrome

Post-Viral Fatigue Syndrome

Canada
University of Pennsylvania

Recruiting

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)

Giant Cell Arteritis | Microscopic Polyangiitis | Polyarteritis Nodosa | Granulomatosis With Polyangiitis | Takayasu Arteritis | Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Churg-Strauss Syndrome (CSS)

United States, Canada
Fred Hutchinson Cancer Center
Yale University; Asociación Civil Impacta Salud y Educación, Peru

Completed

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

HIV | Alcohol Use Disorder

Peru
David Oslin
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Pharmacogenetic Response to Naltrexone For Alcohol Dependence

Alcohol Dependence

United States
Santa Barbara Cottage Hospital

Withdrawn

Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease

United States
Odense University Hospital

Completed

Potential Health Effects of Aronia Intake

Health Effects of Aronia

Denmark
State University of New York - Upstate Medical...
Cephalon

Completed

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) (vivitrol)

Alcohol Dependence | Schizophrenia | Schizoaffective Disorders | Bipolar Disorders

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Effect of rTMS in Pathological Gamblers

Pathological Gambler

France
Bangor University

Completed

Beetroot Juice as a Potential Ergogenic Aid During Exercise in Hypoxia

Hypoxia

United Kingdom
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Alcohol Dependence

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Combined Treatment for Cocaine-Alcohol Dependence - 1

Alcohol Dependence | Cocaine Dependence

United States

Search clinical trials for: Placebo, then Naltrexone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations